We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
+8.96%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$73.6B
AUM Growth
+$1.15B
(+1.6%)
Cap. Flow
-$3.6B
Cap. Flow
% of AUM
-4.89%
Top 10 Holdings %
Top 10 Hldgs %
20.8%
Holding
3,102
New
50
Increased
790
Reduced
2,114
Closed
100
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NXP Semiconductors
NXPI
|
+$38.7M |
| 2 |
International Flavors & Fragrances
IFF
|
+$27.4M |
| 3 |
Neurocrine Biosciences
NBIX
|
+$14.7M |
| 4 |
ConocoPhillips
COP
|
+$14.5M |
| 5 |
Royalty Pharma
RPRX
|
+$9.46M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$269M |
| 2 |
Microsoft
MSFT
|
+$172M |
| 3 |
Amazon
AMZN
|
+$114M |
| 4 |
Walt Disney
DIS
|
+$62.4M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$61.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.61% |
| 2 | Financials | 14.26% |
| 3 | Healthcare | 12.86% |
| 4 | Consumer Discretionary | 12.27% |
| 5 | Industrials | 9.79% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2251
Protagonist Therapeutics
PTGX
$9.44B
| $860K | ﹤0.01% |
33,215
-520
| -2% | -$13.2K |
|
|
LGF.A
2252
DELISTED
Lions Gate Entertainment Corp. Class A Voting Shares
LGF.A
| $860K | ﹤0.01% |
57,554
+565
| +1% | +$8.47K |
|
2253
Ribbon Communications
RBBN
$383M
| $859K | ﹤0.01% |
104,625
-6,280
| -6% | -$52K |
|
2254
Corsair Gaming
CRSR
$1.55B
| $858K | ﹤0.01% |
25,775
+8,277
| +47% | +$308K |
|
2255
Cato Corp
CATO
$66.1M
| $857K | ﹤0.01% |
71,451
-1,093
| -2% | -$12.9K |
|
|
QADA
2256
DELISTED
QAD Inc.
QADA
| $855K | ﹤0.01% |
12,839
-775
| -6% | -$51.9K |
|
2257
Rhythm Pharmaceuticals
RYTM
$7.96B
| $854K | ﹤0.01% |
40,155
-1,423
| -3% | -$41.3K |
|
|
BPYU
2258
DELISTED
Brookfield Property REIT Inc. Class A Common Stock
BPYU
| $854K | ﹤0.01% |
47,597
-4,495
| -9% | -$79.7K |
|
2259
Luxfer Holdings
LXFR
$458M
| $853K | ﹤0.01% |
40,068
-2,509
| -6% | -$47.2K |
|
2260
Miller Industries
MLR
$619M
| $850K | ﹤0.01% |
18,408
-660
| -3% | -$27.7K |
|
2261
XPEL
XPEL
$1.38B
| $849K | ﹤0.01% |
16,343
-675
| -4% | -$36.3K |
|
|
PETQ
2262
DELISTED
PetIQ, Inc. Class A Common Stock
PETQ
| $848K | ﹤0.01% |
24,058
-1,745
| -7% | -$61.8K |
|
|
XENT
2263
DELISTED
Intersect ENT, Inc
XENT
| $847K | ﹤0.01% |
40,584
-2,630
| -6% | -$60.7K |
|
2264
Financial Institutions
FISI
$821M
| $845K | ﹤0.01% |
27,897
-985
| -3% | -$26.6K |
|
2265
Tucows
TCX
$175M
| $845K | ﹤0.01% |
10,907
-752
| -6% | -$60.6K |
|
|
ACBI
2266
DELISTED
Atlantic Capital Bancshares, Inc. Common Stock
ACBI
| $844K | ﹤0.01% |
35,035
-2,720
| -7% | -$55.6K |
|
2267
Keros Therapeutics
KROS
$221M
| $842K | ﹤0.01% |
13,675
+64
| +0.5% | +$4.05K |
|
2268
Tidewater
TDW
$4.12B
| $841K | ﹤0.01% |
67,153
-4,320
| -6% | -$52.4K |
|
|
APTS
2269
DELISTED
Preferred Apartment Communities, Inc.
APTS
| $841K | ﹤0.01% |
85,379
-4,004
| -4% | -$34.1K |
|
2270
Broadstone Net Lease
BNL
$4.02B
| $839K | ﹤0.01% |
45,825
+570
| +1% | +$10.5K |
|
|
CIO
2271
DELISTED
City Office REIT
CIO
| $838K | ﹤0.01% |
78,862
-3,887
| -5% | -$39.7K |
|
2272
Energy Recovery
ERII
$443M
| $837K | ﹤0.01% |
45,622
-4,690
| -9% | -$75.1K |
|
|
MORF
2273
DELISTED
Morphic Holding, Inc. Common Stock
MORF
| $836K | ﹤0.01% |
13,208
-815
| -6% | -$37.4K |
|
2274
1-800-Flowers.com
FLWS
$258M
| $835K | ﹤0.01% |
30,242
-3,678
| -11% | -$109K |
|
|
WOW
2275
DELISTED
WideOpenWest
WOW
| $835K | ﹤0.01% |
61,475
-4,095
| -6% | -$53.8K |
|
Similar funds
VAM
RhumbLine Advisers's Q1 2021 Portfolio in Review
As of Q1 2021, RhumbLine Advisers held 3,102 positions worth $73.6B, up 1.6% from $72.5B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
RhumbLine Advisers withdrew a net $3.6B in Q1 2021, closing 100 positions and reducing 2,114 holdings. Its most notable exit was Tiffany & Co., an estimated $26.8M position sold in full.
By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 24% a quarter earlier, followed by Financials and Healthcare.
Against the trend, RhumbLine Advisers opened a new position in NXP Semiconductors worth $42.7M.
- RhumbLine Advisers's largest Q1 2021 buy was NXP Semiconductors: 211,843 shares worth $42.7M.
- RhumbLine Advisers added most to International Flavors & Fragrances in Q1 2021, an estimated $27.4M increase.
- RhumbLine Advisers's biggest Q1 2021 reduction was Apple, cutting an estimated $269M.
- RhumbLine Advisers fully exited Tiffany & Co. in Q1 2021, selling an estimated $26.8M.
- RhumbLine Advisers's ten largest holdings make up 21% of its $73.6B portfolio in Q1 2021.
- RhumbLine Advisers opened 50 new positions and closed 100 in Q1 2021.
- RhumbLine Advisers's portfolio value rose 1.6% quarter-over-quarter to $73.6B.
Based on RhumbLine Advisers's 13F filing for Q1 2021, filed 6 May 2021.